PMV Pharmaceuticals Inc. (NASDAQ: PMVP)
$1.5900
-0.0200 ( -1.24% ) 43.5K
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
Market Data
Open
$1.5900
Previous close
$1.6100
Volume
43.5K
Market cap
$82.54M
Day range
$1.5750 - $1.7260
52 week range
$1.4000 - $3.4700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 69 | Nov 07, 2024 |
| 8-k | 8K-related | 12 | Nov 07, 2024 |
| 4 | Insider transactions | 1 | Oct 03, 2024 |
| 4 | Insider transactions | 1 | Oct 03, 2024 |
| 4 | Insider transactions | 1 | Oct 03, 2024 |
| 4 | Insider transactions | 1 | Sep 12, 2024 |
| 4 | Insider transactions | 1 | Sep 12, 2024 |
| 10-q | Quarterly Reports | 69 | Aug 08, 2024 |
| 8-k | 8K-related | 20 | Aug 08, 2024 |
| 4 | Insider transactions | 2 | Jun 10, 2024 |